Zyloprim: Effective Uric Acid Control for Gout Management
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.35 | $63.28 $63.28 (0%) | 🛒 Add to cart |
| 270 | $0.32 | $94.92 $87.39 (8%) | 🛒 Add to cart |
| 360 | $0.31
Best per pill | $126.56 $110.49 (13%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.19 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $64.79 $53.24 (18%) | 🛒 Add to cart |
| 120 | $0.54 | $86.38 $64.28 (26%) | 🛒 Add to cart |
| 180 | $0.47 | $129.57 $84.37 (35%) | 🛒 Add to cart |
| 270 | $0.42 | $194.36 $114.51 (41%) | 🛒 Add to cart |
| 360 | $0.40
Best per pill | $259.15 $144.64 (44%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
Zyloprim, with the active ingredient allopurinol, is a xanthine oxidase inhibitor prescribed for the long-term management of gout and conditions involving elevated uric acid levels (hyperuricemia). It works by reducing the production of uric acid in the body, thereby preventing the formation of uric acid crystals that cause painful gout attacks and kidney stones. This medication is a cornerstone of urate-lowering therapy, aimed at normalizing serum urate levels and preventing disease progression. Proper adherence to treatment can significantly reduce the frequency of acute gout flares and the risk of chronic joint damage.
Features
- Active ingredient: Allopurinol 100 mg or 300 mg tablets
- Pharmacologic class: Xanthine oxidase inhibitor
- Reduces uric acid synthesis by inhibiting the enzyme xanthine oxidase
- Available in scored tablets for accurate dosing
- Typically administered once daily, following a meal or glass of milk
Benefits
- Prevents the formation of new uric acid crystals in joints and tissues
- Reduces the frequency and severity of acute gout attacks over time
- Lowers the risk of developing chronic tophaceous gout and joint erosion
- Helps prevent uric acid kidney stone formation
- May improve overall kidney function in patients with hyperuricemia-related nephropathy
- Supports long-term management of hyperuricemia associated with chemotherapy
Common use
Zyloprim is primarily indicated for the management of gout, both primary and secondary, and for the treatment of hyperuricemia that may occur with blood cancers or their treatment. It is also used to manage uric acid nephropathy and recurrent uric acid stone formation. The medication is not intended for the treatment of acute gout attacks but rather for prophylaxis against future episodes.
Dosage and direction
The initial dosage of Zyloprim typically ranges from 100 to 300 mg daily, depending on the severity of the condition and renal function. For mild gout, 100-200 mg daily may be sufficient, while severe tophaceous gout may require 400-600 mg daily. The dosage should be individualized based on serum uric acid levels, with target levels generally below 6 mg/dL. It is recommended to take Zyloprim after meals to minimize gastric upset. Dosage adjustments are necessary in patients with renal impairment.
Precautions
Patients should maintain adequate hydration (2-3 liters of fluid daily) unless contraindicated. Regular monitoring of liver function, renal function, and complete blood count is recommended during therapy. Use with caution in patients with pre-existing liver disease or bone marrow suppression. Zyloprim may initially precipitate acute gout attacks; concurrent prophylactic anti-inflammatory therapy (e.g., colchicine or NSAIDs) is often recommended during the first 3-6 months of treatment.
Contraindications
Zyloprim is contraindicated in patients who have exhibited hypersensitivity to allopurinol or any component of the formulation. It should not be used during an acute gout attack unless patients are on stable maintenance therapy. The medication is contraindicated in patients being treated with didanosine or azathioprine/mercaptopurine without appropriate dosage adjustment and monitoring.
Possible side effect
Common side effects may include skin rash (discontinue immediately if rash appears), nausea, vomiting, diarrhea, and drowsiness. Less frequently, patients may experience elevated liver enzymes, leukopenia, thrombocytopenia, or peripheral neuropathy. Rare but serious adverse effects include severe hypersensitivity reactions (DRESS syndrome, Stevens-Johnson syndrome), hepatitis, and vasculitis.
Drug interaction
Zyloprim may potentiate the effects of azathioprine, mercaptopurine, and theophylline by inhibiting their metabolism. It may increase the risk of bone marrow suppression when used with other myelosuppressive agents. Concurrent use with ampicillin/amoxicillin increases the risk of skin rash. Diuretics, especially thiazides, may decrease the excretion of allopurinol metabolites. Warfarin effects may be enhanced, requiring closer INR monitoring.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure consistent uric acid control.
Overdose
Symptoms of overdose may include nausea, vomiting, diarrhea, and dizziness. In severe cases, acute renal failure may occur. Management involves supportive care and hydration. Hemodialysis may be effective in removing allopurinol and its metabolites. There is no specific antidote for allopurinol overdose.
Storage
Store at room temperature (15-30°C or 59-86°F) in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Zyloprim is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Dosage and treatment duration should be determined by a physician based on individual patient factors. Patients should not alter their treatment regimen without consulting their healthcare provider.
Reviews
Clinical studies and patient reports consistently demonstrate Zyloprim’s effectiveness in reducing serum uric acid levels and preventing gout attacks when used appropriately long-term. Many patients experience significant improvement in quality of life with reduced frequency of painful flares. Some users report initial gastrointestinal discomfort that often resolves with continued use. The medication is generally well-tolerated when dosage is properly adjusted for renal function and concomitant medications are managed appropriately.